Volume : 13, Issue : 10, October – 2026
Title:
DEVELOPMENT OF LIPOSOMAL DRUG DELIVERY SYSTEM FOR TARGETED DELIVERY OF 5-FLUOROURACIL (5-FU)
Authors :
E. Beaula Rani*, Yadiki Poojitha, Boppajada Praveen, Ramavath Priyanka, Prudhvi Gorati, Bathula Raju
Abstract :
The present study was aimed at the formulation and evaluation of 5-Fluorouracil-loaded liposomes to enhance drug encapsulation, provide sustained drug release, and improve formulation stability. Liposomes were prepared using the thin-film hydration method by varying the concentration of cholesterol while maintaining a constant concentration of phosphatidylcholine. FTIR compatibility studies demonstrated the absence of significant interactions between the drug and excipients, confirming their compatibility.SEM analysis revealed that the prepared liposomes were spherical in shape with smooth surface morphology. The particle size of the formulations ranged from 175 to 258 nm, with formulation F3 exhibiting the smallest particle size (175 nm). Drug entrapment efficiency was found to vary among the formulations, with F3 showing the highest entrapment efficiency of 85.19%.In vitro drug release studies demonstrated sustained release behavior over an 8-hour period, with formulation F3 exhibiting the highest cumulative drug release of 98.51%. Stability studies conducted under various storage conditions (25°C/60% RH, 30°C/75% RH, and 40°C/75% RH) for three months indicated no significant changes in the physicochemical characteristics or drug release profile of the optimized formulation, confirming its stability.The findings of this study suggest that 5-Fluorouracil-loaded liposomes represent a promising drug delivery system capable of providing enhanced drug entrapment, sustained release, and improved stability. Among the developed formulations, F3 was identified as the optimized formulation based on its superior physicochemical characteristics and release profile. Further in vivo studies are warranted to establish the therapeutic efficacy and clinical applicability of the developed liposomal formulation.
Keywords: 5-Fluorouracil, Liposomes, Thin-Film Hydration Method, Entrapment Efficiency, Sustained Drug Release, Stability Studies.
Cite This Article:
Please cite this article in press E. Beaula Rani et al., Development Of Liposomal Drug Delivery System For Targeted Delivery Of 5-Fluorouracil (5-Fu).,. Indo Am. J. P. Sci, 2026; 13(10).
REFERENCES:
1. Benita S. Microencapsulation Method and Industrial Application, Drug and The Pharmaceutical sciences. Vol.73 2002. p. 213.
2. Fuji G. Vesicles, Realization of the Drug Delivery Concept. Vol.62 1996. New York p. 491-495.
3. Bangham AD, Standish MM. Diffusion of univalent ions across the lamella of swollen Phospholipids. J. Mol. Biol. 1965; 13: 238-252.
4. Vyas SP, Khar RK. Targeted and controlled Drug Delivery, Novel Carrier system, CBS Publishers and distributors. 2002. p. 249.
5. Gregoriadis G. Liposome technology, Liposome preparation and related techniques, 3rd edition, vol. l 2007. p. 21.
6. Singh S, Gulati M. Advances in liposomal therapeutics, Targeting of drugs to lipid bilayer in liposomes: an approach for the success of liposomes as delivery systems. CBS Publishers and distributors. New Delhi. 2001. p. 4-34.
7. Scherphof G, Morselt H, Regts J. The involvement of the lipid phase transition in the plasma-induced dissolution of multilamellar phosphatidylcholine vesicles. Biochem. Biophys. Acta.1979;556:196–207.
8. Jain NK. Controlled and novel drug Delivery, CBS Publishers and distributors.2002. p. 305,326,330.
9. Bangham AD. Techniques in life Science, lipid membrane biochemistry. Elsevier scientific publications. Ireland. 1982 p.1-25.
10. Drummond DC, Meyer O, Hong K. Pharmacokinetic study of liposome encapsulated drug. Pharmacological reviews 1999; 51(4): 691-743.11.
11. Lasic DD. Stealth liposomes,Microencapsulation Method and Industrial Applications. Vol. 73 1996 p. 297-311.
12. Crommelin DJ, Schreier H. Liposomes, Colloidal Drug Delivery Systems. 1996 p. 73-157.
13. Liu R, Cannon JB, Li Y. Liposomes in Solubilization. Water Insoluble Drug FormulationCRC Press, New York. 2000; 355-358.
14. Patel HM, Ryman BR. Systemic and Oral administration of liposomes. Physical Structure to therapeutic applications 1981; 409-439.
15. Jaggi M, Khar RK. Liposomes as Drug Carriers. Indian Drugs 1989; 27(8):404.
16. Krensky AM, Strom TB. Immunomodulators: Immunosuppressive agents, Tolerogens and Immunostimulants. Goodman and Gilman’s The Pharmacological Basis of TherapeuticsLimbird LE (Ed.) 10th Ed, 2001 p. 1466-1480.